Constellium (NYSE: CSTM) grants 10,210-share restricted award to SVP

Rhea-AI Filing Summary

Jurkovic Philip Ryan reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE senior vice president and CHRO Philip Ryan Jurkovic received a grant of 10,210 restricted stock units representing ordinary shares as executive compensation. The award was reported at a price of zero per share and increases his direct holdings to 220,933 ordinary shares.

The restricted stock units vest in full on March 12, 2029, subject to his continued employment, meaning he must remain with the company until that date to receive the underlying shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Jurkovic Philip Ryan

Role SVP & CHRO

Type	Security	Shares	Price	Value
Grant/Award	Ordinary shares	10,210	$0.00	--

Holdings After Transaction: Ordinary shares — 220,933 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jurkovic Philip Ryan

(Last) (First) (Middle)

300 EAST LOMBARD STREET

SUITE 1710

(Street)

BALTIMORE MD 21202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONSTELLIUM SE [ CSTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & CHRO

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares	03/12/2026	03/12/2026	A		10,210(1)	A	$0	220,933	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units of Constellium SE, which vest in full on March 12, 2029, subject to the Reporting Person's continued employment.

Remarks:

	/s/ Kristine Carpenter, Attorney-in-Fact for Philip Ryan Jurkovic	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Constellium (CSTM) report for Philip Ryan Jurkovic?

Constellium reported that SVP and CHRO Philip Ryan Jurkovic received a grant of 10,210 restricted stock units. These units represent ordinary shares and were granted at a reported price of zero per share as part of his executive compensation package.

How many Constellium shares does Philip Ryan Jurkovic hold after this Form 4 grant?

After the reported grant, Philip Ryan Jurkovic directly holds 220,933 ordinary shares of Constellium. This total includes the newly awarded 10,210 restricted stock units, which are reflected as part of his post-transaction holdings in the Form 4 filing.

When do Philip Ryan Jurkovic’s newly granted Constellium restricted stock units vest?

The 10,210 restricted stock units granted to Philip Ryan Jurkovic vest in full on March 12, 2029. Vesting is conditional on his continued employment with Constellium through that date, aligning the award with long-term service and retention.

What does the Form 4 filing reveal about the price of the Constellium stock award?

The Form 4 shows the 10,210 ordinary shares underlying the restricted stock unit grant with a transaction price of 0.0000 per share. This indicates a compensation-related award rather than an open-market purchase by the executive.

What is Philip Ryan Jurkovic’s role at Constellium mentioned in the Form 4?

The filing identifies Philip Ryan Jurkovic as an officer of Constellium, serving as senior vice president and chief human resources officer. His role is explicitly listed as “SVP & CHRO,” confirming he is a key member of the executive leadership team.